Handbook of Cancer and Immunology - Rezaei, Nima; (szerk.) - Prospero Internetes Könyváruház
Kosár (0)
Kívánságlista (0)
Értesítés a kedvenc témákról
__

 
A termék adatai:
ISBN13:9783031401213
ISBN10:3031401212
Kötéstípus:Keménykötés
Terjedelem:8904 oldal
Méret:235x155 mm
Nyelv:angol
Illusztrációk: 52 Illustrations, black & white; 706 Illustrations, color
700
Témakör:

Handbook of Cancer and Immunology

 
Kiadás sorszáma: 1st ed. 2025
Kiadó: Springer
Megjelenés dátuma:
Kötetek száma: 19 pieces, Book
 
Normál ár:
Kiadói listaár:
EUR 6954.99
Becsült forint ár:
3 023 334 Ft (2 879 365 Ft + 5% áfa)
Miért becsült?
 
Az Ön ára:
2 781 467 (2 649 016 Ft + 5% áfa )
Kedvezmény(ek): 8% (kb. 241 867 Ft)
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
 
Beszerezhetőség:
Még nem jelent meg, de rendelhető. A megjelenéstől számított néhány héten belül megérkezik.
 
Kosárba teszek
  példányt

 
Hosszú leírás:

The rapid flow of studies in the field of cancer and immunology during the last decades has increased our understanding of the interactions between the immune system and cancerous cells. In particular, it has been well-known that such interactions result in the induction of epigenetic changes in cancerous cells and the selection of less immunogenic clones as well as alterations in immune responses. Understanding the crosstalk between nascent transformed cells and cells of the immune system has led to the development of combinatorial immunotherapeutic strategies to combat cancer.


The Handbook of Cancer and Immunology offers a comprehensive and up-to-date review of cancer immunology and immunotherapy, emphasizing key findings and clinically relevant data. This reference work is an essential resource for researchers, students, academics, and clinicians committed to advancing knowledge, diagnostics, and treatments in this vital field.

Tartalomjegyzék:
T cell metabolism and its regulation by checkpoint molecules.- Tumor evasion of the immune system: the role of INF and TNF in cancer.- Intra-tumor cell heterogeneity: different immune responses for different cells.- Epithelial-mesenchymal plasticity, a link between inflammation and cancer metastasis.- Spatial technologies: a game changer to study tumor microenvironment.- Advances in tumor microenvironment immuneprofiling.- Immunodiagnostics: A perspective of tumor-specific antigen expression, specificity, and stability.- Immunohistochemistry as a tool to guide diagnosis, treatment, and prognosis in brain tumors.- Immune check point inhibitors and anti-angiogenic therapy for cancer.- Immune checkpoint inhibitors in unresectable hepatocellular carcinoma patients.- Synthetic-based Tumor-infiltrating lymphocytes (TILs) in adoptive cell therapies.- Development of next-generation antibody therapeutics using DDS and molecular imaging.- Immunotherapy for triple-negative breast cancer.- Immunotherapy for endocrine cancers.- Novel cancer treatment using oncolytic virus therapy.- Lysine acetylation inhibitors (KATi) as novel therapeutics.- CRISPR-Cas9 in personalized treatment in cancer.- Antibody-functionalized nanoparticles for targeted drug delivery in cancer therapy.- Challenges in computational pathology of biomarkers-driven predictive and prognostic immunotherapy.- Diagnosis and management of toxicities associated with immunotherapy in cancer.